🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Voice Worries

However, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and banned related hashtags and query recommendations. The company said it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, populated with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.

Within moments of joining one group, a vendor shared contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Product Information and Costs

Inside these groups, posts show black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram stated it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Even if the research behind this drug is sound, these online versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to possibly serious medical dangers”.